[News Article]PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Weon Sup Lee, Head of R&D center and PharmAbcine R&D staffs...
[News Article]PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Weon Sup Lee, Head of R&D center and PharmAbcine R&D staffs...
2F, Research Building 2, 70,
Yuseong-daero 1689 beon-gil,
Yuseong-gu, Daejeon, 34047, Republic of Korea
HQ +82-42-863-2017
R&D Center +82-42-861-2017
Investor Relations +70-4294-6097
FAX +82-42-863-2080
COPYRIGHT BY PharmAbcine Inc.
ALL RIGHTS RESERVE
PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Weon Sup Lee, Head of R&D center and PharmAbcine R&D staffs have attended and presented their R&D progress of both TTAC-0001 (Tanibirumab) and PMC-309 projects funded by KDDF at KDDF R&D workshop 2018 (September 6-7) at Sun Valley Hotel in Yeoju, KOREA.
http://www.yakup.com/news/index.html?nid=221281&mode=view